<DOC>
	<DOCNO>NCT02749747</DOCNO>
	<brief_summary>- Introduction : Estrogen hormonal therapy associate progestagen standard therapy treatment hot flush . However woman candidate hormone replacement therapy medical reason choice . - Main goal : Reducing number hot flush per week - Materials Methods : A double-blind sulpiride versus placebo include select randomized patient show symptoms menopause . Study conduct Hospital de Cl√≠nicas de Porto Alegre ( Brazil ) 8 week intervention . The expected result significant reduction number hot flush / day evaluate daily questionnaire</brief_summary>
	<brief_title>Sulpiride Versus Placebo Reducting Hot Flushes During Climacteric</brief_title>
	<detailed_description>It hold 4 visit . The V0 ( first one ) implement consent form , review inclusion exclusion criterion laboratory exam deliver diary book hot flush . The V1 ( second visit ) randomization provide medication first 30 day . The V2 ( third visit ) make record diary hot flush already fill , deliver new specification provide medication last 30 day . The V3 ( fourth visit ) evaluate record diary hot flush already complete make final evaluation study .</detailed_description>
	<mesh_term>Hot Flashes</mesh_term>
	<mesh_term>Sulpiride</mesh_term>
	<criteria>Healthy woman postmenopausal woman least five moderate intense hot flush per day Use hormone replacement therapy psychiatric drug least 3 month Hypersensitivity sulpiride Current history prolactin dependent tumor Treating breast cancer treat Diagnosed suspect pheochromocytoma Current use levodopa Abnormal heart rhythm ( QT prolongation , bradycardia low 55 beat per minute ) Hypokalemia serious electrolyte disturbance Current treat stroke Pregnancy breastfeeding</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Menopause</keyword>
	<keyword>nonhormonal treatment</keyword>
	<keyword>sulpiride</keyword>
</DOC>